GenoMines Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
42
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$44.3M
- Investors
-
24
GenoMines General Information
Description
Provider of plant-based mining services intended for sustainable mining. The company's metal hyperaccumulator plants utilize synthetic biology to enhance the natural ability of plants to absorb metals, enabling miners to increase their revenue while capturing atmospheric carbon dioxide in the process.
Contact Information
Website
www.genomines.comCorporate Office
- 17 Bis Avenue des Andes
- 91940 Les Ulis
- France
Corporate Office
- 17 Bis Avenue des Andes
- 91940 Les Ulis
- France
GenoMines Timeline
GenoMines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Early Stage VC (Series A) | 17-Sep-2025 | $44.3M | Completed | Generating Revenue | ||
| 8. Accelerator/Incubator | 25-Apr-2025 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 28-Nov-2023 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 18-Oct-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 28-Sep-2022 | Completed | Generating Revenue | |||
| 4. Seed Round | 20-Oct-2021 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2021 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2021 | $107K | Completed | Startup | ||
| 1. Accelerator/Incubator | 01-Jan-2021 | $107K | $107K | Completed | Startup |
GenoMines Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
GenoMines Patents
GenoMines Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2025266712-A1 | Methods and plants for phytomining | Pending | 29-Apr-2024 | ||
| WO-2025228961-A1 | Methods and plants for phytomining | Pending | 29-Apr-2024 | ||
| AU-2025265854-A1 | Process for recovering nickel from nickel-hyperaccumulator plant biochar | Pending | 29-Apr-2024 | ||
| WO-2025229028-A1 | Process for recovering nickel from nickel-hyperaccumulator plant biochar | Pending | 29-Apr-2024 | A01H6/14 |
GenoMines Signals
GenoMines Investors (24)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Albo Club | Impact Investing | Minority | ||
| AlphaTech Investment Group | Asset Manager | Minority | ||
| DeepTech & Climate Fonds | Venture Capital | Minority | ||
| Engine Ventures | Venture Capital | Minority | ||
| Forbion | Venture Capital | Minority |
GenoMines FAQs
-
When was GenoMines founded?
GenoMines was founded in 2021.
-
Where is GenoMines headquartered?
GenoMines is headquartered in Les Ulis, France.
-
What is the size of GenoMines?
GenoMines has 42 total employees.
-
What industry is GenoMines in?
GenoMines’s primary industry is Other Metals, Minerals and Mining.
-
Is GenoMines a private or public company?
GenoMines is a Private company.
-
What is the current valuation of GenoMines?
The current valuation of GenoMines is .
-
What is GenoMines’s current revenue?
The current revenue for GenoMines is .
-
How much funding has GenoMines raised over time?
GenoMines has raised $49.4M.
-
Who are GenoMines’s investors?
Albo Club, AlphaTech Investment Group, DeepTech & Climate Fonds, Engine Ventures, and Forbion are 5 of 24 investors who have invested in GenoMines.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process